# Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy Patients

> **NCT02283450** · — · COMPLETED · sponsor: **Harbin Medical University** · enrollment: 30 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** Qiliqiangxin Capsule

## Key facts

- **NCT ID:** NCT02283450
- **Lead sponsor:** Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02283450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02283450, "Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02283450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*